Ancestim biosimilar - ProfarmaAlternative Names: PF-09; Recombinant human stem cell factor - Profarma; Recombinant SCF - Profarma
Latest Information Update: 17 Jun 2015
At a glance
- Originator Profarma
- Class Antianaemics; Antineoplastics; Stem cell factors
- Mechanism of Action Colony stimulating factor stimulants; Stem cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer
Most Recent Events
- 17 Jun 2015 Early research in Cancer in Lithuania (Parenteral) (Profarma pipeline, June 2015)
- 02 Apr 2015 Profarma has patent protection for ancestim biosimilar (Profarma website, June 2015)